These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 17290691)
1. Prognostic factors in gastric carcinoma with peritoneal dissemination. Kim DY; Joo JK; Park YK; Ryu SY; Kim YJ; Kim SK Acta Chir Belg; 2006; 106(6):665-8. PubMed ID: 17290691 [TBL] [Abstract][Full Text] [Related]
2. Is palliative resection necessary for gastric carcinoma patients? Kim DY; Joo JK; Park YK; Ryu SY; Kim YJ; Kim SK; Lee JH Langenbecks Arch Surg; 2008 Jan; 393(1):31-5. PubMed ID: 17593384 [TBL] [Abstract][Full Text] [Related]
3. T4 gastric carcinoma: the benefit of non-curative resection. Kim DY; Joo JK; Seo KW; Park YK; Ryu SY; Kim HR; Kim YJ; Kim SK ANZ J Surg; 2006 Jun; 76(6):453-7. PubMed ID: 16768767 [TBL] [Abstract][Full Text] [Related]
4. Pancreaticoduodenectomy for advanced gastric carcinoma patients. Ryu SY; Kim HG; Lee JH; Kim DY Acta Chir Belg; 2013; 113(5):346-50. PubMed ID: 24294799 [TBL] [Abstract][Full Text] [Related]
5. Reduced preoperative serum albumin and absence of peritoneal dissemination may be predictive factors for long-term survival with advanced gastric cancer with positive cytology test. Yamashita K; Ushiku H; Katada N; Hosoda K; Moriya H; Mieno H; Kikuchi S; Hoshi K; Watanabe M Eur J Surg Oncol; 2015 Oct; 41(10):1324-32. PubMed ID: 26251341 [TBL] [Abstract][Full Text] [Related]
6. Prognosis of gastric carcinoma invading the mesocolon. Ryu SY; Joo JK; Park YK; Kim YJ; Kim SK; Lee JH; Kim DY Asian J Surg; 2008 Oct; 31(4):179-84. PubMed ID: 19010759 [TBL] [Abstract][Full Text] [Related]
7. Body mass index (BMI) may be a prognostic factor for gastric cancer with peritoneal dissemination. Chen S; Nie RC; OuYang LY; Li YF; Xiang J; Zhou ZW; Chen Y; Peng J World J Surg Oncol; 2017 Feb; 15(1):52. PubMed ID: 28228146 [TBL] [Abstract][Full Text] [Related]
8. [Treatment results of peritoneal dissemination from gastric cancer by neoadjuvant intraperitoneal-systemic chemotherapy]. Yonemura Y; Kawamura T; Bando E; Takahashi S; Sawa T; Yoshimitsu Y; Obata T; Endo Y; Sasaki T; Sugarbaker PH Gan To Kagaku Ryoho; 2004 Oct; 31(11):1723-6. PubMed ID: 15553695 [TBL] [Abstract][Full Text] [Related]
9. Factors correlated with peritoneal carcinomatosis and survival in patients with gastric cancer treated at a single institution in Brazil. Fanelli MF; Silva MJ; de Paiva TF; Chinen LT; GuimarĂ£es AP; Gimenes DL; Pinheiro ED; Rinck JA; Nicolau UR; Sanches SM; Melo CA; Dettino AL; Cruz MR; de Melo LM; Formiga MN; de Lima VC Int J Clin Oncol; 2009 Aug; 14(4):326-31. PubMed ID: 19705243 [TBL] [Abstract][Full Text] [Related]
10. Surgical resection with hyperthermic intraperitoneal chemotherapy for gastric cancer patients with peritoneal dissemination. Li C; Yan M; Chen J; Xiang M; Zhu ZG; Yin HR; Lin YZ J Surg Oncol; 2010 Oct; 102(5):361-5. PubMed ID: 20872942 [TBL] [Abstract][Full Text] [Related]
11. Regional lymph node metastasis as a predictor of peritoneal carcinomatosis in patients with Borrmann type IV gastric carcinoma. Otsuji E; Yamaguchi T; Sawai K; Sakakura C; Okamoto K; Takahashi T Am J Gastroenterol; 1999 Feb; 94(2):434-7. PubMed ID: 10022642 [TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of an R1 resection in gastric cancer patients treated with adjuvant chemoradiotherapy. Stiekema J; Trip AK; Jansen EP; Boot H; Cats A; Ponz OB; Verheij M; van Sandick JW Ann Surg Oncol; 2014 Apr; 21(4):1107-14. PubMed ID: 24306660 [TBL] [Abstract][Full Text] [Related]
13. [Related factors and prognosis of hepatic metastasis and peritoneal dissemination in gastric cancer]. Wang Z; Zhan WH; He YL; Cai SR; Peng JS; Chen CQ; Ma JP; Zheng ZQ Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Jul; 9(4):287-90. PubMed ID: 16886104 [TBL] [Abstract][Full Text] [Related]
14. The Benefits of Resection for Gastric Carcinoma Patients with Non-curative Factors. Lee JH; Kim HG; Ryu SY; Kim DY Chonnam Med J; 2018 Jan; 54(1):36-40. PubMed ID: 29399564 [TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic prognostic factors in patients with Borrmann type 4 gastric cancer: univariate and multivariate analyses. Yokota T; Kunii Y; Saito T; Teshima S; Narushima Y; Yamada Y; Iwamoto K; Kagami M; Takahashi M; Kikuchi S; Yamauchi H Ups J Med Sci; 2000; 105(3):227-34. PubMed ID: 11261608 [TBL] [Abstract][Full Text] [Related]
16. Clinical significance of cytological status of peritoneal lavage fluid during intraperitoneal chemotherapy for gastric cancer with overt peritoneal dissemination. Emoto S; Kitayama J; Ishigami H; Yamaguchi H; Watanabe T Ann Surg Oncol; 2015 Mar; 22(3):780-6. PubMed ID: 25216603 [TBL] [Abstract][Full Text] [Related]
17. Clinicopathological features of patients with Borrmann type IV gastric carcinoma. Kim DY; Kim HR; Kim YJ; Kim S ANZ J Surg; 2002 Oct; 72(10):739-42. PubMed ID: 12534387 [TBL] [Abstract][Full Text] [Related]
18. Is histologic differentiation a prognostic indicator for gastric carcinoma patients with curative resection? Ryu SY; Kim HG; Joo JK; Kang H; Lee JH; Kim DY Indian J Cancer; 2015; 52(1):45-7. PubMed ID: 26837970 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of non-curative gastrectomy for incurable gastric carcinoma. Jeong O; Park YK; Choi WY; Ryu SY Ann Surg Oncol; 2014 Aug; 21(8):2587-93. PubMed ID: 24633671 [TBL] [Abstract][Full Text] [Related]
20. Comparison of clinicopathological features of gastric carcinoma, between 2 times periods, at a single institute in China. Jianhui C; Yulong H; Chuangqi C; Kaiming W; Xinhua Z; Shirong C J Cancer Res Ther; 2015; 11(4):874-81. PubMed ID: 26881534 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]